Annual Gross profit royalty amount.

No definition available.

Name:	AITB_AnnualGrossProfitRoyaltyAmount
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Annual Gross profit royalty percentage.

+ References

No definition available.

+ Details

Name:	AITB_AnnualGrossProfitRoyaltyPercentage
Namespace Prefix:	AITB_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

First two milestone ordinary shares.

+ References

No definition available.

+ Details

Name:	AITB_FirstTwoMilestoneOrdinaryShares
Namespace Prefix:	AITB_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

First two milestone ordinary shares, value.

+ References

No definition available.

+ Details

Name:	AITB_FirstTwoMilestoneOrdinarySharesValue
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Milestones payment.

+ References

No definition available.

+ Details

Name:	AITB_MilestonesPayment
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

One-time royalty percentage.

+ References

No definition available.

+ Details

Name:	AITB_OnetimeRoyaltyPercentage
Namespace Prefix:	AITB_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Payment of milestone ordinary shares.

+ References

No definition available.

+ Details

Name:	AITB_PaymentOfMilestoneOrdinaryShares
Namespace Prefix:	AITB_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Payment of milestone ordinary shares, value.

+ References

No definition available.

+ Details

Name:	AITB_PaymentOfMilestoneOrdinarySharesValue
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments in cash discounted, percentage.

+ References

No definition available.

+ Details

Name:	AITB_PaymentsInCashDiscountedPercentage
Namespace Prefix:	AITB_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue allocated to performance obligations.

+ References

No definition available.

+ Details

Name:	AITB_RevenueAllocatedToPerformanceObligations
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of consideration recognized during the period for the milestone or milestones.

+ References

No definition available.

+ Details

Name:	AITB_RevenueRecognitionMilestoneMethodRevenueRecognized1
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Royalty gross profit amount.

+ References

No definition available.

+ Details

Name:	AITB_RoyaltyGrossProfitAmount
Namespace Prefix:	AITB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Royalty percentage owed on sale of licensed product revenues.

+ References

No definition available.

+ Details

Name:	AITB_RoyaltyOwedExpressedAsPercentageOfLicensedProductRevenue
Namespace Prefix:	AITB_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_DeferredRevenueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of cash paid for royalties during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

+ Details

Name:	us-gaap_PaymentsForRoyalties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=AITB_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=AITB_FirstObligationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=AITB_SecondObligationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=AITB_CircassiaPharmaceuticalsPLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=AITB_HospitalAndClinicSettingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_CN
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=AITB_UnitedStatesAndChinaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License Agreement (Details Narrative) - USD ($)		3 Months Ended
License Agreement (Details Narrative) - USD ($)	Jan. 23, 2019	Mar. 31, 2019	Mar. 31, 2018
Deferred revenue		$ 2,263,294
License Agreement [Member]
Regulatory milestone amount	$ 31,500,000
Payments in cash discounted, percentage	5.00%
First two milestone ordinary shares		17,572,815
First two milestone ordinary shares, value		$ 9,987,295
License Agreement [Member] \| First Obligation Member [Member]
Deferred revenue		2,871,063
License Agreement [Member] \| Second Obligation Member [Member]
Deferred revenue		607,769
License Agreement [Member] \| Intellectual Property [Member] \| First Obligation Member [Member]
Revenue allocated to performance obligations		$ 7,116,232
License Agreement [Member] \| Circassia Pharmaceuticals PLC [Member]
Milestones payment	$ 7,350,000
Royalty percentage owed on sale of licensed product revenues.	5.00%
Payment of milestone ordinary shares, value	$ 3,150,000
Payment of milestone ordinary shares	5,271,844
Annual Gross profit royalty percentage	14.00%
Annual Gross profit royalty amount	$ 100,000,000
License Agreement [Member] \| Circassia Pharmaceuticals PLC [Member] \| Hospital and Clinic Settings [Member]
Payments for royalties	8,400,000
License Agreement [Member] \| Circassia Pharmaceuticals PLC [Member] \| United States [Member]
Payments for royalties	$ 12,600,000
One-time royalty percentage	5.00%
Royalty gross profit amount	$ 50,000,000
License Agreement [Member] \| Circassia Pharmaceuticals PLC [Member] \| China [Member]
Payments for royalties	$ 1,050,000
One-time royalty percentage	5.00%
Royalty gross profit amount	$ 20,000,000
License Agreement [Member] \| Circassia Pharmaceuticals PLC [Member] \| United States and China [Member]
Annual Gross profit royalty percentage	15.00%
Annual Gross profit royalty amount	$ 100,000,000
License Agreement [Member] \| Maximum [Member]
Milestones payment	$ 32,500,000
License Agreement [Member] \| Maximum [Member] \| Circassia Pharmaceuticals PLC [Member]
Annual Gross profit royalty percentage	19.00%
Annual Gross profit royalty amount	$ 100,000,000
License Agreement [Member] \| Maximum [Member] \| Circassia Pharmaceuticals PLC [Member] \| United States and China [Member]
Annual Gross profit royalty percentage	20.00%
Annual Gross profit royalty amount	$ 100,000,000